Scinai Immunotherapeutics (SCNI)

• Market cap: $2.74M
• 1 day: 6.76%
• 5 days: -29.46%
• 1 month: -20.15%
• 3 months: -49.68%
• 6 months: -64.25%
• Year to date: -77.03%
• 1 year: -76.56%
• 5 years: -99.76%
• 10 years: -99.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Employees: 31